A 24-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of the rivastigmine patch in Japanese patients with Alzheimer' s disease

Bibliographic Information

Title
A 24-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of the rivastigmine patch in Japanese patients with Alzheimer' s disease
Author
Nakamura Y, Fujii A, Graf A, lmai Y, Kim H, Mori J, Shigeta M, Shirahase T, Homma A

Journal

Related Projects

See more

Details 詳細情報について

  • CRID
    1010000782086070530
  • Article Type
    journal article
  • Data Source
    • KAKEN

Report a problem

Back to top